Carbamide Forte

Carbamide Forte is owned by Forte Healthcare, which is headquartered in India. We trace ownership to the ultimate parent — not just the local subsidiary — using public corporate filings and disclosures.

Our ownership score weighs four signals: equity ownership (40%), parent company country and strategic control (20%), manufacturing in India (10%), and revenue retained in India (10%), plus structural and HQ proxies. Full methodology is published at /methodology.

Indian-controlled alternatives in the same category include Rheumatil Tablet, Dabur Broncorid Syrup, Healthkart, Kapiva, Healthkart. Each alternative is verified against the same ownership framework — strategic control, equity, and economic value retained in India.

Carbamide Forte is primarily mapped to Personal Care. We map every brand to its primary category and segment so you can compare like-for-like alternatives instead of unrelated products.

We re-verify ownership data on a rolling weekly cadence. Major changes — parent company shifts, classification flips, or score moves greater than 5 points — are published in the public ownership change log within 24 hours.